<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38518038</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>22</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Long COVID's Impact on Patients, Workers, &amp; Society: A review.</ArticleTitle><Pagination><StartPage>e37502</StartPage><MedlinePgn>e37502</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e37502</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000037502</ELocationID><Abstract><AbstractText>The incidence of long COVID in adult survivors of an acute SARS-CoV-2 infection is approximately 11%. Of those afflicted, 26% have difficulty with day-to-day activities. The majority of long COIVD cases occur after mild or asymptomatic acute infection. Children can spread SARS-CoV-2 infections and can also develop long-term neurological, endocrine (type I diabetes), and immunological sequelae. Immunological hypofunction is exemplified by the recent large outbreaks of respiratory syncytial virus and streptococcal infections. Neurological manifestations are associated with anatomical brain damage demonstrated on brain scans and autopsy studies. The prefrontal cortex is particularly susceptible. Common symptoms include brain fog, memory loss, executive dysfunction, and personality changes. The impact on society has been profound. Fewer than half of previously employed adults who develop long COVID are working full-time, and 42% of patients reported food insecurity and 20% reported difficulties paying rent. Vaccination not only helps prevent severe COVID-19, but numerous studies have found beneficial effects in preventing and mitigating long COVID. There is also evidence that vaccination after an acute infection can lessen the symptoms of long COVID. Physical and occupational therapy can also help patients regain function, but the approach must be "low and slow." Too much physical or mental activity can result in post-exertional malaise and set back the recovery process by days or weeks. The complexity of long COVID presentations coupled with rampant organized disinformation, have caused significant segments of the public to ignore sound public health advice. Further research is needed regarding treatment and effective public communication.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kavanagh</LastName><ForeName>Kevin T</ForeName><Initials>KT</Initials><Identifier Source="ORCID">0000-0002-4588-6509</Identifier><AffiliationInfo><Affiliation>Health Watch, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cormier</LastName><ForeName>Lindsay E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Health Watch USA, Eastern Kentucky University, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontus</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Watch USA, Massachusetts Nurses Association, Canton, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergman</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maryland Department of Health, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webley</LastName><ForeName>Wilmore</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Massachusetts Amherst, Amherst, MA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>14</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38518038</ArticleId><ArticleId IdType="pmc">PMC10957027</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000037502</ArticleId><ArticleId IdType="pii">00005792-202403220-00050</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vanichkachorn G. Symptoms, Treatment and Rehabilitation of Patients With Long COVID. Health Watch USA. 2023.</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. World Health Organization. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [access date November 7, 2023].</Citation></Reference><Reference><Citation>CDC. Post-COVID Conditions: Information for Healthcare Providers. CDC. 2023. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html [access date November 7, 2023].</Citation></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Notarte KI, Peligro PJ, et al. . Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14:2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, et al. . Long COVID and significant activity limitation among adults, by age&#x2014;United States, June 1-13, 2022, to June 7-19, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:866&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Qasmieh SA, Robertson MM, Teasdale CA, et al. . The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022. Prev Med. 2023;169:107461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9940463</ArticleId><ArticleId IdType="pubmed">36813250</ArticleId></ArticleIdList></Reference><Reference><Citation>Frallonardo L, Segala FV, Chhaganlal KD, et al. . Incidence and burden of long COVID in Africa: a systematic review and meta-analysis. Sci Rep. 2023;13:21482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10700349</ArticleId><ArticleId IdType="pubmed">38057338</ArticleId></ArticleIdList></Reference><Reference><Citation>Experiences of Canadians with long-term symptoms following COVID-19 (Statistics Canada) (2023).</Citation></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Notarte KI, Macasaet R, et al. . Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: a systematic review and meta-analysis. J Infect. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J Clin Med. 2022;11:7314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson MM, Qasmieh SA, Kulkarni SG, et al. . The epidemiology of long coronavirus disease in US adults. Clin Infect Dis. 2023;76:1636&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">36542514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health Malaysia FHDD. Annex 2m Guideline on home monitoring and management of confirmed COVID-19 case at COVID-19 assessment centre in primary care. 2022.</Citation></Reference><Reference><Citation>Moy FM, Hairi NN, Lim ERJ, et al. . Long COVID and its associated factors among COVID survivors in the community from a middle-income country&#x2014;an online cross-sectional study. PLoS One. 2022;17:e0273364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426885</ArticleId><ArticleId IdType="pubmed">36040960</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Author correction: long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10408714</ArticleId><ArticleId IdType="pubmed">37069455</ArticleId></ArticleIdList></Reference><Reference><Citation>Webley W. Long COVID&#x2019;s Impact on Patients, Workers &amp; Society. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10957027</ArticleId><ArticleId IdType="pubmed">38518038</ArticleId></ArticleIdList></Reference><Reference><Citation>Iasonidou E. Long COVID: A Pediatrician&#x2019;s View as a Patient and Doctor. Health Watch USA. 2023.</Citation></Reference><Reference><Citation>Birx D. The Impact of Long COVID on the United States. Presented at: Long COVID's Impact on Patients, Workers &amp; Society. 2023. Videocast available at: https://youtu.be/jQMFHEFWpiM [access date January 12, 2024].</Citation></Reference><Reference><Citation>Walitt BT. Exploring the Post-Acute Sequelae of COVID-19 at the National Institutes of Health. Presented at: Long COVID's Impact on Patients, Workers &amp; Society. 2023. Videocast available at: https://youtu.be/DZT3l0mZeH8 [access date January 12, 2024].</Citation></Reference><Reference><Citation>Elders J. Vaccine Hesitancy and Closing Remarks. Long COVID&#x2019;s Impact on Patients, Workers &amp; Society. 2023. Available at: https://www.youtube.com/watch?v=6Ol1z-fTI28.</Citation></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, et al. . Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci Rep. 2023;13:11207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert NSC. COVID-19 &#x201c;Long Hauler&#x201d; Symptoms Survey Report. COVID-19 &#x201c;Long Hauler&#x201d; Symptoms Survey Report. Indiana University School of Medicine; 2020.</Citation></Reference><Reference><Citation>Kavanagh K. Conclusion. Long COVID&#x2019;s Impact on Patients, Workers &amp; Society. 2023. Available at: https://www.youtube.com/watch?v=6Ol1z-fTI28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10957027</ArticleId><ArticleId IdType="pubmed">38518038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. . Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotopf M, Noah N, Wessely S. Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. J Neurol Neurosurg Psychiatry. 1996;60:504&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC486361</ArticleId><ArticleId IdType="pubmed">8778253</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. . NIH COVID-19 Autopsy Consortium. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hany M, Sheta E, Talha A, et al. . Incidence of persistent SARS-CoV-2 gut infection in patients with a history of COVID-19: insights from endoscopic examination. Endosc Int Open. 2024;12:E11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10769582</ArticleId><ArticleId IdType="pubmed">38188925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, et al. . Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022;42:1523&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Engelmann I, Moreau AS, et al. . High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021;51:296&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816954</ArticleId><ArticleId IdType="pubmed">33495765</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, Zhang S, Porritt RA, et al. . Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci U S A. 2020;117:25254&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med. 1996;212:99&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">8650257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdy A, Leonardi A. Superantigens and SARS-CoV-2. Pathogens. 2022;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9026686</ArticleId><ArticleId IdType="pubmed">35456065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang H, Sun Y, et al. . Potential associations between microbiome and COVID-19. Front Med (Lausanne). 2021;8:785496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727742</ArticleId><ArticleId IdType="pubmed">35004750</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Mahroum N, Bogdanos DP, et al. . COVID-19 as an infectome paradigm of autoimmunity. J Allergy Clin Immunol. 2022;149:63&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610602</ArticleId><ArticleId IdType="pubmed">34826507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Martinez MM, Carrera Boada C, Madera-Silva MD, et al. . COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2021;33:151&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantea Stoian A, Bica IC, Salmen T, et al. . New-onset diabetes mellitus in COVID-19: a scoping review. Diabetes Ther. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10786767</ArticleId><ArticleId IdType="pubmed">37751143</ArticleId></ArticleIdList></Reference><Reference><Citation>Unsworth R, Wallace S, Oliver NS, et al. . New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020;43:e170&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32816997</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile G, Kulkarni RN, Morgan NG. How, when, and where do human beta-cells regenerate? Curr Diab Rep. 2019;19:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986204</ArticleId><ArticleId IdType="pubmed">31250214</ArticleId></ArticleIdList></Reference><Reference><Citation>Stathi D, Triantafyllidis KK, Zafeiri M, et al. . COVID-19 induced type 1 diabetes: a systematic review of case reports and series. J Int Med Res. 2023;51:3000605231210403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10637179</ArticleId><ArticleId IdType="pubmed">37940619</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero RG, Riera LB, Marcos NS, et al. . New-onset type 1 diabetes mellitus in the paediatric emergency department: impact of the COVID-19 pandemic. Ann Pediatr Endocrinol Metab. 2023;28:215&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10556438</ArticleId><ArticleId IdType="pubmed">37798896</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan KMV, Staimez LR. Rising diabetes diagnosis in long COVID. Lancet Diabetes Endocrinol. 2022;10:298&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937249</ArticleId><ArticleId IdType="pubmed">35325625</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z, Velasquez Garcia HA, Wong S, et al. . Association of COVID-19 infection with incident diabetes. JAMA Netw Open. 2023;6:e238866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10114057</ArticleId><ArticleId IdType="pubmed">37071420</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu AY, Wang SH, Duong TQ. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study. BMJ Open Diabetes Res Care. 2023;11:e003257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10276968</ArticleId><ArticleId IdType="pubmed">37295808</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;65:949&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh TYJ, Chang R, Yong SB, et al. . COVID-19 vaccination prior to SARS-CoV-2 infection reduced risk of subsequent diabetes mellitus: a real-world investigation using U.S. electronic health records. Diabetes Care. 2023;46:2193&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">37851392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Ashman M, Taha MK, et al. . Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51:418&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114587</ArticleId><ArticleId IdType="pubmed">33991720</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, et al. . Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61:2200970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorchenko Y, Zimba O. Long COVID in autoimmune rheumatic diseases. Rheumatol Int. 2023;43:1197&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10061411</ArticleId><ArticleId IdType="pubmed">36995436</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur JM, Forrest JC, Boehme KW, et al. . Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021;16:e0257016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rollins CK, Calderon J, Wypij D, et al. . Overcoming COVID-19 Investigators. Neurological and psychological sequelae associated with multisystem inflammatory syndrome in children. JAMA Netw Open. 2023;6:e2324369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10357334</ArticleId><ArticleId IdType="pubmed">37466939</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, et al. . Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinkeles Melchers NVS, Nawijn F, Rumke LW, et al. . [Invasive group A streptococcal infections in the Netherlands]. Ned Tijdschr Geneeskd. 2023;167:D7118..</Citation><ArticleIdList><ArticleId IdType="pubmed">36928399</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N, Lansiaux E, Reinis A. Group A streptococcal (GAS) infections amongst children in Europe: taming the rising tide. New Microbes New Infect. 2023;51:101071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9803947</ArticleId><ArticleId IdType="pubmed">36593885</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Sweden. Current weekly report on RS virus.
The Public Health Agency of Sweden. Available at: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistik-a-o/sjukdomsstatistik/rsv-veckorapporter/aktuell-veckorapport-om-rsv/ [access date December 7, 2023].</Citation></Reference><Reference><Citation>Bergmann S, Lindstr&#xf6;m M. Sweden&#x2019;s Pandemic Experiment. 1st ed. Routledge. 2022:332.</Citation></Reference><Reference><Citation>Wang L, Davis PB, Berger N, et al. . Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study. Fam Med Community Health. 2023;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10582888</ArticleId><ArticleId IdType="pubmed">37832975</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande M, Fitzek A, Puschel K, et al. . Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28:721&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469258</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande M, Fitzek A, Spitzer M, et al. . Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19. Br J Ophthalmol. 2022;106:1313&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042582</ArticleId><ArticleId IdType="pubmed">33836988</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho PM, Marcos AAA, Romano AC, et al. . Retinal findings in patients with COVID-19. Lancet. 2020;395:1610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217650</ArticleId><ArticleId IdType="pubmed">32405105</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, et al. . Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218:e20202135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris F. Can&#x2019;t think, can&#x2019;t remember: more Americans say they&#x2019;re in a cognitive fog.
NY Times. 2023. Available at: https://www.nytimes.com/2023/11/13/upshot/long-covid-disability.html.</Citation></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, et al. . Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein TL. Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 &#x201c;long haulers.&#x201d;. BMC Neurol. 2023;23:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843113</ArticleId><ArticleId IdType="pubmed">36647063</ArticleId></ArticleIdList></Reference><Reference><Citation>Salimi M, Ghazvineh S, Zare M, et al. . Distraction of olfactory bulb-medial prefrontal cortex circuit may induce anxiety-like behavior in allergic rhinitis. PLoS One. 2019;14:e0221978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738655</ArticleId><ArticleId IdType="pubmed">31509547</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S, Di Lorenzo F, Scarioni M, et al. . Is the frontal lobe the primary target of SARS-CoV-2? J Alzheimers Dis. 2021;81:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair RJ. The roles of orbital frontal cortex in the modulation of antisocial behavior. Brain Cogn. 2004;55:198&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">15134853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P, Ferrazzoli D, Sebastianelli L, et al. . Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19. Eur J Neurol. 2022;29:1652&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111319</ArticleId><ArticleId IdType="pubmed">35138693</ArticleId></ArticleIdList></Reference><Reference><Citation>Redelmeier DA, Wang J, Thiruchelvam D. COVID vaccine hesitancy and risk of a traffic crash. Am J Med. 2023;136:153&#x2013;162.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9716428</ArticleId><ArticleId IdType="pubmed">36470796</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Martin EM, Reuken P, et al. . Long COVID is associated with severe cognitive slowing. medRxiv. 2023; 2023120323299331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10839583</ArticleId><ArticleId IdType="pubmed">38318123</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, et al. . Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;67.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Belluck P. Scientists offer a new explanation for Long Covid.
NY Times. 2023. Available at: https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html.</Citation></Reference><Reference><Citation>Lin SH, Lee LT, Yang YK. Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clin Psychopharmacol Neurosci. 2014;12:196&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4293164</ArticleId><ArticleId IdType="pubmed">25598822</ArticleId></ArticleIdList></Reference><Reference><Citation>da Cunha-Bang S, Knudsen GM. The modulatory role of serotonin on human impulsive aggression. Biol Psychiatry. 2021;90:447&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">34266672</ArticleId></ArticleIdList></Reference><Reference><Citation>Smallwood N, Willis K. Mental health among healthcare workers during the COVID-19 pandemic. Respirology. 2021;26:1016&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661789</ArticleId><ArticleId IdType="pubmed">34467596</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkstone J. How Prozac could help Long Covid sufferers: a study has found some symptoms may be alleviated by taking anti-depressants.
The Telegraph. 2023. Available at: https://www.telegraph.co.uk/news/2023/10/17/prozac-could-help-long-covid-sufferers-symptoms/.</Citation></Reference><Reference><Citation>Public Health Agency of Sweden. Weekly Report on Covid-19, Week 5. Report. 2020. Available at: https://www.folkhalsomyndigheten.se/globalassets/statistik-uppfoljning/smittsamma-sjukdomar/veckorapporter-covid-19/2020/veckorapport-covid-19-v50-final.pdf.</Citation></Reference><Reference><Citation>University of Oxford. COVID-19 is a leading cause of death in children and young people in the US.
2023. Available at: https://www.ox.ac.uk/news/2023-01-31-covid-19-leading-cause-death-children-and-young-people-us.</Citation></Reference><Reference><Citation>Beusekom MV. Not &#x201c;little adults&#x201d;: Experts say long COVID undercounted, misdiagnosed in kids.
2023. Available at: https://www.cidrap.umn.edu/covid-19/not-little-adults-experts-say-long-covid-undercounted-misdiagnosed-kids [access date December 7, 2023].</Citation></Reference><Reference><Citation>Pellegrino R, Chiappini E, Licari A, et al. . Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181:3995&#x2013;4009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk AL, Kuppermann N, Florin TA, et al. . Pediatric Emergency Research Network&#x2013;COVID-19 Study Team. Post-COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw Open. 2022;5:e2223253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, et al. . Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176:1000&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Pujol FE, Munblit D, et al. . Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children. Future Microbiol. 2022;17:577&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Camporesi A, Morello R, et al. . Social stigma in children with long COVID. Children (Basel). 2023;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10529184</ArticleId><ArticleId IdType="pubmed">37761479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, et al. . Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. NPJ Vaccines. 2022;7:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, et al. . Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2:e000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayyerabadi M, Fourcade L, Joshi SA, et al. . Vaccination after developing long COVID: impact on clinical presentation, viral persistence, and immune responses. Int J Infect Dis. 2023;136:136&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">37717649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, et al. . Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Kulzhabayeva D, Rodrigues NB, et al. . COVID-19 vaccination for the prevention and treatment of long COVID: a systematic review and meta-analysis. Brain Behav Immun. 2023;111:211&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. . Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Kobayashi T, Callado GY, et al. . The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3:e168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris L, Leach S, Xu Y, et al. . Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ. 2023;383:e076990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10666099</ArticleId><ArticleId IdType="pubmed">37993131</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach K. New data shows long Covid is keeping as many as 4 million people out of work.
2022. Available at: https://www.brookings.edu/articles/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work.</Citation></Reference><Reference><Citation>Burns A. What are the Implications of Long COVID for Employment and Health Coverage?
2022. Available at: https://www.kff.org/policy-watch/what-are-the-implications-of-long-covid-for-employment-and-health-coverage/ [access date December 10, 2023].</Citation></Reference><Reference><Citation>Belluck P. Long Covid is keeping significant numbers of people out of work, study finds.
NY Times. 2023. Available at: https://www.nytimes.com/2023/01/24/health/long-covid-work.html.</Citation></Reference><Reference><Citation>Belluck P. How Long COVID Is Affecting People&#x2019;s Jobs and Their Needs at Work. Health Watch USA. 2023.</Citation></Reference><Reference><Citation>O&#x2019;Kelly B, Vidal L, McHugh T, et al. . Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. Brain Behav Immun Health. 2022;24:100485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale J. Long Covid study links lingering virus with bowel-to-brain havoc.
Bloomberg. 2023. Available at: https://www.bloomberg.com/news/articles/2023-10-16/prozac-has-potential-to-treat-long-covid-s-body-wide-symptoms-study-finds.</Citation></Reference><Reference><Citation>Yang C, Zhao H, Espin E, et al. . Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir Med. 2023;11:504&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10171832</ArticleId><ArticleId IdType="pubmed">37178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams R. Humans may be more likely to believe disinformation generated by AI.
Available at: https://www.technologyreview.com/2023/06/28/1075683/humans-may-be-more-likely-to-believe-disinformation-generated-by-ai/amp.</Citation></Reference><Reference><Citation>Fried I. How AI will turbocharge misinformation &#x2013; and what we can do about it.
Axios. 2023. Available at: https://www.axios.com/2023/07/10/ai-misinformation-response-measures.</Citation></Reference><Reference><Citation>Menn J. Russians boasted that just 1% of fake social profiles are caught, leak shows.
The Washington Post. 2023. Available at: https://www.washingtonpost.com/technology/2023/04/16/russia-disinformation-discord-leaked-documents/.</Citation></Reference><Reference><Citation>Menz BD, Modi ND, Sorich MJ, et al. . Health disinformation use case highlighting the urgent need for artificial intelligence vigilance: weapons of mass disinformation. JAMA Intern Med. 2023;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">37955873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas G. Combating Disinformation regarding COVID-19 and Long COVID. 2023.</Citation></Reference><Reference><Citation>Van Noorden R. How big is science&#x2019;s fake-paper problem? Nature. 2023;623:466&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37949983</ArticleId></ArticleIdList></Reference><Reference><Citation>Liverpool L. AI intensifies fight against &#x2018;paper mills&#x2019; that churn out fake research. Nature. 2023;618:222&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">37258739</ArticleId></ArticleIdList></Reference><Reference><Citation>Orc. Study laundering: Retracted antivax studies resurrected in fake journals. Respectful Insolence. 2023. Available at: https://www.respectfulinsolence.com/2023/11/06/study-laundering-retracted-antivax-studies-resurrected-in-fake-journals.</Citation></Reference><Reference><Citation>Center APP. Vaccine Confidence Falls as Belief in Health Misinformation Grows. Available at: https://www.annenbergpublicpolicycenter.org/vaccine-confidence-falls-as-belief-in-health-misinformation-grows/.</Citation></Reference><Reference><Citation>Emmott R. Russia deploying coronavirus disinformation to sow panic in West, EU document says.
Reuters. 2020. Available at: https://www.reuters.com/article/us-health-coronavirus-disinformation/russia-deploying-coronavirus-disinformation-to-sow-panic-in-west-eu-document-says-idUSKBN21518F/.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Weekly COVID-19 Vaccination Dashboard.
Available at: https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/vaccination-dashboard.html [access date December 4, 2023].</Citation></Reference><Reference><Citation>Seither R, Yusuf OB, Dramann D, et al. . Coverage with selected vaccines and exemption from school vaccine requirements among children in kindergarten&#x2014;United States, 2022-23 school year. MMWR Morb Mortal Wkly Rep. 2023;72:1217&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10651323</ArticleId><ArticleId IdType="pubmed">37943705</ArticleId></ArticleIdList></Reference><Reference><Citation>Armour S. Veterinarians confront a human problem: anti-Vaxxers.
Wall Street J. 2023. Available at: https://www.msn.com/en-us/news/us/veterinarians-confront-a-human-problem-anti-vaxers/ar-AA1icFUe.</Citation></Reference><Reference><Citation>Hotez P. Global Vaccines and Vaccinations: The Science vs The Anti-Science. 2023. Available at: https://www.healthconference.org/.</Citation></Reference><Reference><Citation>Amin K, Ortaliza J, Cox C, et al. . COVID-19 preventable mortality. KFF Health News. 2022. Available at: https://www.kff.org/coronavirus-covid-19/issue-brief/covid-19-continues-to-be-a-leading-cause-of-death-in-the-u-s/ [access date December 10, 2023].</Citation></Reference><Reference><Citation>Simmons-Duffin S, Nakajima K. This is how many lives could have been saved with COVID vaccinations in each state. Radio Broadcast. 2022.
All Things Considered. 2022. Available at: https://www.npr.org/sections/health-shots/2022/05/13/1098071284/this-is-how-many-lives-could-have-been-saved-with-covid-vaccinations-in-each-sta.</Citation></Reference><Reference><Citation>Leonhardt D. Red Covid: Covid&#x2019;s partisan pattern is growing more extreme.
N.Y. Times. 2021. Available at: https://www.nytimes.com/2021/09/27/briefing/covid-red-states-vaccinations.html.</Citation></Reference><Reference><Citation>Thomason J. The Impact of Long COVID on Nurses. Workers &amp; Society. Health Watch USA; 2023.</Citation></Reference><Reference><Citation>Kennedy B, Tyson A. Americans&#x2019; Trust in Scientists, Positive Views of Science Continue to Decline. Report. 2023. Available at: https://www.pewresearch.org/science/2023/11/14/americans-trust-in-scientists-positive-views-of-science-continue-to-decline/ [access date December 10, 2023].</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Smoking and Diabetes. 2022. Available at: https://www.cdc.gov/diabetes/library/features/smoking-and-diabetes.html [access date December 10, 2023].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>